500 related articles for article (PubMed ID: 26669487)
61. Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas.
Sivasankaran B; Degen M; Ghaffari A; Hegi ME; Hamou MF; Ionescu MC; Zweifel C; Tolnay M; Wasner M; Mergenthaler S; Miserez AR; Kiss R; Lino MM; Merlo A; Chiquet-Ehrismann R; Boulay JL
Cancer Res; 2009 Jan; 69(2):458-65. PubMed ID: 19147558
[TBL] [Abstract][Full Text] [Related]
62. Lineage-Restricted OLIG2-RTK Signaling Governs the Molecular Subtype of Glioma Stem-like Cells.
Kupp R; Shtayer L; Tien AC; Szeto E; Sanai N; Rowitch DH; Mehta S
Cell Rep; 2016 Sep; 16(11):2838-2845. PubMed ID: 27626655
[TBL] [Abstract][Full Text] [Related]
63. Ikaros represses the transcriptional response to Notch signaling in T-cell development.
Kleinmann E; Geimer Le Lay AS; Sellars M; Kastner P; Chan S
Mol Cell Biol; 2008 Dec; 28(24):7465-75. PubMed ID: 18852286
[TBL] [Abstract][Full Text] [Related]
64. Canonical
Herrick DB; Guo Z; Jang W; Schnittke N; Schwob JE
J Neurosci; 2018 May; 38(21):5022-5037. PubMed ID: 29739871
[TBL] [Abstract][Full Text] [Related]
65. Differential expression of Notch family members in astrocytomas and medulloblastomas.
Xu P; Yu S; Jiang R; Kang C; Wang G; Jiang H; Pu P
Pathol Oncol Res; 2009 Dec; 15(4):703-10. PubMed ID: 19424825
[TBL] [Abstract][Full Text] [Related]
66. Canonical Notch2 signaling determines biliary cell fates of embryonic hepatoblasts and adult hepatocytes independent of Hes1.
Jeliazkova P; Jörs S; Lee M; Zimber-Strobl U; Ferrer J; Schmid RM; Siveke JT; Geisler F
Hepatology; 2013 Jun; 57(6):2469-79. PubMed ID: 23315998
[TBL] [Abstract][Full Text] [Related]
67. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.
Bruna A; Darken RS; Rojo F; Ocaña A; Peñuelas S; Arias A; Paris R; Tortosa A; Mora J; Baselga J; Seoane J
Cancer Cell; 2007 Feb; 11(2):147-60. PubMed ID: 17292826
[TBL] [Abstract][Full Text] [Related]
68. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
69. Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura.
Ma D; Dai J; Zhu X; Yan S; Zhao P; Zhang J; Zhu Y; Sun J; Peng J; Ji C; Hou M
Ann Hematol; 2010 Feb; 89(2):155-61. PubMed ID: 19603167
[TBL] [Abstract][Full Text] [Related]
70. RBP-Jκ-dependent Notch signaling enhances retinal pigment epithelial cell proliferation in transgenic mice.
Schouwey K; Aydin IT; Radtke F; Beermann F
Oncogene; 2011 Jan; 30(3):313-22. PubMed ID: 20856205
[TBL] [Abstract][Full Text] [Related]
71. Cysteine and glycine-rich protein 2 is crucial for maintaining the malignant phenotypes of gliomas through its action on Notch signalling cascade.
Liu L; Li F; Zhang L; Cheng Y; Wu L; Tie R; Jiang X; Gao W; Liu B; Wei Y; Chang P; Xu J; Zhao H; Zhang L
Toxicol Appl Pharmacol; 2024 Jun; 487():116969. PubMed ID: 38744347
[TBL] [Abstract][Full Text] [Related]
72. Protective effect of rapamycin on endothelial-to-mesenchymal transition in HUVECs through the Notch signaling pathway.
Tian D; Zeng X; Wang W; Wang Z; Zhang Y; Wang Y
Vascul Pharmacol; 2019 Feb; 113():20-26. PubMed ID: 30336218
[TBL] [Abstract][Full Text] [Related]
73. Early pancreatic islet fate and maturation is controlled through RBP-Jκ.
Cras-Méneur C; Conlon M; Zhang Y; Pasca Di Magliano M; Bernal-Mizrachi E
Sci Rep; 2016 May; 6():26874. PubMed ID: 27240887
[TBL] [Abstract][Full Text] [Related]
74. Fibulin-3 promotes glioma growth and resistance through a novel paracrine regulation of Notch signaling.
Hu B; Nandhu MS; Sim H; Agudelo-Garcia PA; Saldivar JC; Dolan CE; Mora ME; Nuovo GJ; Cole SE; Viapiano MS
Cancer Res; 2012 Aug; 72(15):3873-85. PubMed ID: 22665268
[TBL] [Abstract][Full Text] [Related]
75. Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model.
Baumgart A; Mazur PK; Anton M; Rudelius M; Schwamborn K; Feuchtinger A; Behnke K; Walch A; Braren R; Peschel C; Duyster J; Siveke JT; Dechow T
Oncogene; 2015 Jan; 34(5):578-88. PubMed ID: 24509876
[TBL] [Abstract][Full Text] [Related]
76. Notch activation inhibits AML growth and survival: a potential therapeutic approach.
Kannan S; Sutphin RM; Hall MG; Golfman LS; Fang W; Nolo RM; Akers LJ; Hammitt RA; McMurray JS; Kornblau SM; Melnick AM; Figueroa ME; Zweidler-McKay PA
J Exp Med; 2013 Feb; 210(2):321-37. PubMed ID: 23359069
[TBL] [Abstract][Full Text] [Related]
77. The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma.
Lee DW; Ramakrishnan D; Valenta J; Parney IF; Bayless KJ; Sitcheran R
PLoS One; 2013; 8(2):e57489. PubMed ID: 23451236
[TBL] [Abstract][Full Text] [Related]
78. Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells.
Zhang C; Hai L; Zhu M; Yu S; Li T; Lin Y; Liu B; Zhou X; Chen L; Zhao P; Zhou H; Huang Y; Zhang K; Ren B; Yang X
Oncotarget; 2017 May; 8(20):33353-33364. PubMed ID: 28380416
[TBL] [Abstract][Full Text] [Related]
79. ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells.
Wee B; Pietras A; Ozawa T; Bazzoli E; Podlaha O; Antczak C; Westermark B; Nelander S; Uhrbom L; Forsberg-Nilsson K; Djaballah H; Michor F; Holland EC
Sci Rep; 2016 Jul; 6():25956. PubMed ID: 27456282
[TBL] [Abstract][Full Text] [Related]
80. Isoliquiritigenin inhibits the proliferation and induces the differentiation of human glioma stem cells.
Lin Y; Sun H; Dang Y; Li Z
Oncol Rep; 2018 Feb; 39(2):687-694. PubMed ID: 29251326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
